Skip to main content
Equibles

MILLENNIUM MANAGEMENT LLC

Position in EXEL — Exelixis, Inc.

CIK 1273087 NEW YORK, NY
Back to EXEL Full portfolio

Position in EXEL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$66,309,793
+$26,215,835 QoQ
Shares Held
1,218,706
+30.4% QoQ
Ownership
0.492%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#37
of 756 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EXEL Over Time

Shares Held

Position Value (USD)

Derivatives in EXEL

reported options exposure · as of Jun 30, 2026
CallValue
$12,035,492
CallShares
221,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. EXEL ranks #16 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 468,410 $232,673,299
2 INSM
INSMED Inc
 2,048,005 $218,358,293
3 APGE
Apogee Therapeutics, Inc.
 1,491,404 $197,954,052
4 JAZZ
Jazz Pharmaceuticals plc
 763,880 $184,072,163
5 ONC
BeOne Medicines Ltd.
 543,323 $154,830,755
6 AXSM
Axsome Therapeutics, Inc.
 556,088 $136,113,659
7 BMRN
Biomarin Pharmaceutical Inc
 2,071,816 $118,549,311
8 REGN
Regeneron Pharmaceuticals, Inc.
 165,120 $102,958,924

All Filings in EXEL

Export CSV
36 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $66,309,793 1,218,706
2026-06-30 $12,035,492 221,200
2026-03-31 $2,260,303 52,700
2026-03-31 $40,093,958 934,809
2025-12-31 $24,224,884 552,701
2025-12-31 $4,383,000 100,000
2025-09-30 $44,449,827 1,076,267
2025-06-30 $25,715,081 583,373
2025-03-31 $17,538,735 475,047
2024-12-31 $3,466,530 104,100
2024-12-31 $44,507,847 1,336,572
2024-09-30 $5,273,040 203,200
2024-09-30 $2,076,000 80,000
2024-09-30 $19,030,276 733,344
2024-06-30 $2,318,904 103,200
2024-06-30 $8,666,364 385,686
2024-03-31 $5,481,131 230,979
2023-12-31 $35,581,296 1,483,172
2023-09-30 $37,913,420 1,735,168
2023-06-30 $31,798,810 1,663,988
2023-03-31 $3,059,675 157,634
2022-12-31 $1,415,626 88,256
2022-09-30 $21,134,742 1,347,879
2022-06-30 $20,123,466 966,545
2022-03-31 $9,354,548 412,640
2021-12-31 $9,370,492 512,609
2021-09-30 $8,231,852 389,397
2021-06-30 $546,600 30,000
2021-06-30 $4,924,592 270,285
2021-03-31 $1,581,300 70,000
2021-03-31 $903,600 40,000
2021-03-31 $18,279,511 809,186
2020-12-31 $3,304,043 164,626
2020-09-30 $1,443,405 59,035
2020-06-30 $5,806,139 244,572
2020-03-31 $13,518,096 785,023